IP Library Granted Patent US 12,692,480
Granted Patent B2
US 12,692,480 · App. 17/449,762 · Granted Jul 28, 2026

Isolated adult cells, artificial organs, rehabilitated organs, research tools, organ encasements, organ perfusion systems, and methods for preparing and utilizing the same

Inventors: Martin Yarmush (Newton, MA); Basak E. Uygun (Cambridge, MA); Korkut Uygun (Boston, MA); Maria-Louisa Izamis (Boston, MA); Alejandro Soto-Gutierrez (Boston, MA); Herman Tolboom (Zurich, CH); Hiroshi Yagi (Brookline, MA); Carley Shulman (Sudbury, MA); Jack Milwid (Denver, CO)
Assignees: The General Hospital Corporation; Massachusetts Institute of Technology
C12N5/067A01N1/122A01N1/143A61K35/407A61M1/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,692,480
App. No.
17/449,762
Granted
Jul 28, 2026
Kind
B2
Abstract

One aspect of the invention provides a method for harvesting adult cells from an organ. The method includes perfusing the organ with a perfusate and isolating adult cells from the organ, thereby harvesting the adult cells from the organ. Another aspect of the invention provides a method for rehabilitating an organ. The method includes: dividing the organ into a first portion and a second portion, perfusing the first portion with a decellularization medium, isolating adult cells from the second portion, and recellularizing the first portion with a suspension of the adult cells, thereby rehabilitating the organ.

Claims (16)

1 . A method for harvesting adult cells from an organ, the method comprising:

(a) perfusing the organ with a perfusate comprising an enzymatic digestion agent and one or more anti-inflammatory agents, wherein the one or more anti-inflammatory agents comprise hydrocortisone;

(b) isolating the adult cells from the organ; and

(c) culturing the adult cells, thereby harvesting the adult cells from the organ.

2 . The method of claim 1 , wherein the organ is a mammalian organ.

3 . The method of claim 2 , wherein the organ is a human organ.

4 . The method of claim 1 , wherein the organ is one selected from the group consisting of: spleen, heart, lung, and kidney.

5 . The method of claim 1 , wherein the organ is ischemic and/or wherein the organ is a damaged organ.

6 . The method of claim 1 , wherein the perfusate includes one or more oxygen carriers, wherein the one or more oxygen carriers comprise erythrocytes.

7 . The method of claim 1 , wherein the enzymatic digestion agent comprises collagenase.

8 . The method of claim 7 , wherein the perfusate is a normothermic perfusate, a room temperature perfusate, or a hypothermic perfusate.

9 . The method of claim 7 , further comprising providing the organ.

10 . The method of claim 7 , further comprising filtering the perfusate through one or more mesh filters having pore sizes ranging from about 1 μm to about 1000 μm.

11 . The method of claim 7 , further comprising performing density centrifugation on the perfusate, or wherein the method further comprises circulating the perfusate through a dialyzer.

12 . The method of claim 7 , wherein the perfusing step improves vitality of the adult cells.

13 . The method of claim 1 , wherein the enzymatic digestion agent is selected from the group consisting of collagenase I, collagenase II, collagenase III, collagenase IV, collagenase V, collagenase VI, trypsin, and hyaluronidase.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2026
From: SHULMAN, CARLEY
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 074800/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2021
From: IZAMIS, MARIA LOUISA; MILWID, JACK
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 057846/0046 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2021
From: YARMUSH, MARTIN; UYGUN, BASAK E.; UYGUN, MUSFATA KORKUT; SOTO-GUTIERREZ, ALEJANDRO; TOLBOOM, HERMAN; YAGI, HIROSHI
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 057846/0146 →
Continuity (6)
Continuation 14645527 · Apr 7, 2015
Continuation 13392661 · Jun 30, 2010
Provisional Application 61330959 · May 4, 2010
Provisional Application 61304860 · Feb 16, 2010
Provisional Application 61222266 · Jul 1, 2009
Related Publication 20220098548A1 · Mar 31, 2022
References Cited (126)
US 1682344A · Lesieur · 1928 [cited by applicant]
US 1916658A · Davidson · 1933 [cited by applicant]
US 3183961A · Herbert · 1965 [cited by applicant]
US 3406531A · Swenson et al. · 1968 [cited by applicant]
US 3468136A · Swenson et al. · 1969 [cited by applicant]
US 3545221A · Swenson et al. · 1970 [cited by applicant]
US 3607646A · Roissart · 1971 [cited by applicant]
US 3660241A · Michielsen · 1972 [cited by applicant]
US 3738914A · Knudson et al. · 1973 [cited by applicant]
US 3772153A · De Roissart · 1973 [cited by applicant]
US 3810367A · Peterson · 1974 [cited by applicant]
US 3843455A · Bier · 1974 [cited by applicant]
US 3877843A · Fischel · 1975 [cited by applicant]
US 3881990A · Burton et al. · 1975 [cited by applicant]
US 3914954A · Doerig · 1975 [cited by applicant]
US 3995444A · Clark et al. · 1976 [cited by applicant]
US 4186565A · Toledo-Pereyra · 1980 [cited by applicant]
US 4242883A · Toledo-Pereyra · 1981 [cited by applicant]
US 4745759A · Bauer et al. · 1988 [cited by applicant]
US 4798824A · Folkert et al. · 1989 [cited by applicant]
US 5356771A · O'Dell · 1994 [cited by applicant]
US 5602026A · Dunn et al. · 1997 [cited by applicant]
US 5942436A · Dunn et al. · 1999 [cited by applicant]
US 6046046A · Hassanein · 2000 [cited by applicant]
US 6524785B1 · Cozzone et al. · 2003 [cited by applicant]
US 6642045B1 · Brasile · 2003 [cited by applicant]
US 7371400B2 · Borenstein et al. · 2008 [cited by applicant]
US 7410474B1 · Friend et al. · 2008 [cited by applicant]
US 7504201B2 · Taylor et al. · 2009 [cited by applicant]
US 7572622B2 · Hassanein et al. · 2009 [cited by applicant]
US 7651835B2 · Hassanein et al. · 2010 [cited by applicant]
US 7691622B2 · Garland et al. · 2010 [cited by applicant]
US 7749693B2 · Brassil et al. · 2010 [cited by applicant]
US 7811808B2 · Plaats et al. · 2010 [cited by applicant]
US 7824848B2 · Owen et al. · 2010 [cited by applicant]
US 8268612B2 · Owen et al. · 2012 [cited by applicant]
US 8287580B2 · Rakhorst et al. · 2012 [cited by applicant]
US 8323954B2 · Kravitz et al. · 2012 [cited by applicant]
US 8440390B2 · Brockbank · 2013 [cited by applicant]
US 8765364B2 · Curtis et al. · 2014 [cited by applicant]
US 8771930B2 · Curtis et al. · 2014 [cited by applicant]
US 8927257B2 · Hutzenlaub et al. · 2015 [cited by applicant]
US 8986978B2 · Brassil et al. · 2015 [cited by applicant]
US 9078428B2 · Hassanein et al. · 2015 [cited by applicant]
US 9215867B2 · Hassanein et al. · 2015 [cited by applicant]
US 9247728B2 · Fishman et al. · 2016 [cited by applicant]
US 11136553B2 · Yarmush et al. · 2021 [cited by applicant]
US 20020039786A1 · Reid · 2002 [cited by applicant]
US 20040058432A1 · Owen et al. · 2004 [cited by applicant]
US 20050147958A1 · Hassanein et al. · 2005 [cited by applicant]
US 20050221269A1 · Taylor et al. · 2005 [cited by applicant]
US 20060019326A1 · Vacanti et al. · 2006 [cited by applicant]
US 20070009881A1 · Arzt et al. · 2007 [cited by applicant]
US 20070042339A1 · Toner et al. · 2007 [cited by applicant]
US 20070148139A1 · Vacanti et al. · 2007 [cited by applicant]
US 20080096184A1 · Brasile · 2008 [cited by applicant]
US 20080234768A1 · Hassanein et al. · 2008 [cited by applicant]
US 20080288399A1 · Curtis et al. · 2008 [cited by applicant]
US 20090123437A1 · Takebe · 2009 [cited by applicant]
US 20110183310A1 · Kravitz et al. · 2011 [cited by applicant]
EP 1246903 · 2002 [cited by applicant]
KR 1020010002227 · 2001 [cited by applicant]
WO WO2007025233 · 2007 [cited by applicant]
WO WO2008024195 · 2008 [cited by applicant]
Miranda et al., Tissue Engineering: Part C, 15(2): 157-167, published online on Dec. 8, 2008. (Year: 2008). [cited by examiner]
Sugimachi et al., “Nonmetabolizable glucose compounds impart cryotolerance to primary rat hepatocytes,” Tissue Eng., Mar. 2006, 12(3):579-88. [cited by applicant]
Amersi et al., “Bucillamine, a thiol antioxidant, prevents transplantation-associate reperfusion injury,” Proc. Natl Acad. Sci., Jun. 2002, 99(13):8915-8920. [cited by applicant]
Bessems et al., “Improved Machine Perfusion Preservation of the Non-Heart-Beating Donor Rat Liver Using Polysol: A New Machine Perfusion Preservation Solution”, Liver Transplantation 11(11):1379-1388 (2005). [cited by applicant]
Bessems et al., “Machine Perfusion Preservation of the Pig Liver Using a New Preservation Solution, Polysol”, Transplant Proceedings 38(5):1238-1242 (2006). [cited by applicant]
Brockmann et al., “Normothermic Perfusion: A New Paradigm for Organ Preservation”, Annals of Surgery 250(1):1-6 (2009). [cited by applicant]
Buis et al., “Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures”, Journal of Hepatology 50(1):69-79 (2009). [cited by applicant]
Butler et al., “Successful Extracorporeal Porcine Liver Perfusion for 72 Hr”, Transplantation 73(8):1212-1218 (2002). [cited by applicant]
Chen et al., “Effective Application of ET-Kyoto Solution for Clinical Lung Transplantation”, Transplantation Proceedings 36(9):2812-2815 (2004). [cited by applicant]
Cypel et al., “Normothermic Ex Vivo Perfusion Prevents Lung Injury Compared to Extended Cold Preservation for Transplantation”, American Journal of Transplantation 9:2262-2269 (2009). [cited by applicant]
De Rougemont et al., “One Hour Hypothermic Oxygenated Perfusion (HOPE) Protects Nonviable Liver Allografts Donated After Cardiac Death”, Ann Surg_ 250(5):674-683 (2009). [cited by applicant]
De Vera et al., “Liver Transplantation Using Donation After Cardiac Death Donors: Long-Term Follow-Up From a Single Center”, American Journal of Transplantation 9:773-781 (2009). [cited by applicant]
Donato et al., Drug Metabolism and Disposition, 33(1):108-114 (2005). “Liver grafts preserved in Celsior solution as source of hepatocytes for drug metabolism studies: comparison with surgical liver biopsies.” [cited by applicant]
Dunn et al., “Long-Term in Vitro Function of Adult Hepatocytes in a Collagen Sandwich Configuration,” Biotechnology Progress, May 1991, 7(3):237-45. [cited by applicant]
Fahy et al., “Cryopreservation of Complex Systems: The Missing Link in the Regenerative Medicine Supply Chain”, Rejuvenation Research 9(2):279-291 (2006). [cited by applicant]
Friend et al., “Normothermic Perfusion of the Isolated Liver”, Transplantation Proceedings 33:3436-3438 (2001). [cited by applicant]
Geuken et al., “Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation”, Journal of Hepatology 41:1017-1025 (2004). [cited by applicant]
Giknis et al., “Clinical Laboratory Parameters for Crl:CD(SD) Rats”, Charles River Laboratories 1-18 (2006). online: http://www.criver.com/sitecollectiondocuments/rm _rm rclinical_parameters_cd_rat_06. [cited by applicant]
Gui et al., “Novel utilization of serum in tissue decellularization,” Tissue Engineering, Apr. 2010, 16(2):173-184. [cited by applicant]
Hertl et al., “Evidence of Preservation Injury to Bile Ducts by Bile Salts in the Pig and Its Prevention by Infusions of Hydrophilic Bile Salts”, Hepatology 21 (4):1130-1137 (1995). [cited by applicant]
Hoekstra et al., “Bile Salt Toxicity Aggravates Cold Ischemic Injury of Bile Ducts After Liver Transplantation in Mdr2 +−/− Mice”, Hepatology, 43(5):1022-1031 (2006). [cited by applicant]
Hoffenberg, “Measurement of the synthesis of liver-produced plasma proteins with particular reference to dietary protein and amino acid supply,” The Biochemical Journal, Sep. 1972, 129(2):3P-3P. [cited by applicant]
Hughes et al., Liver Transplantation, 12:713-717 (2006). “Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation.” [cited by applicant]
Imber et al., “Optimisation of Bile Production during Normothermic Preservation of Porcine Livers”, American Journal of Transplantation 2:593-599 (2002). [cited by applicant]
Jain et al., “Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single Center”, Annals of Surgery 232(4):490-500 (2000). [cited by applicant]
Kamiike et al., “Adenine Nucleotide Metabolism and Its Relation to Organ Viability in Human Liver Transplantation”, Transplantation 45(1):138-143 (1988). [cited by applicant]
Khetani & Bhatia, “Microscale culture of human liver cells for drug development,” Nature Biochemistry Jan. 2008, 26(1):120-126. [cited by applicant]
Lanir et al., “Hepatic Transplantation Survival: Correlation with Adenine Nucleotide Level in Donor Liver,” Hepatology, 8(3):471-475 (1988). [cited by applicant]
Lee et al., “Metabolic Flux Analysis of Postburn Hepatic Hypermetabolism,” Metabolic Engineering 2(4):312-327 (2000). [cited by applicant]
Liu et al., “Operative Outcomes of Adult-to-Adult Right Lobe Live Donor Liver Transplantation: A Comparative Study With Cadaveric Whole-Graft Liver Transplantation in a Single Center,” Annals of Surgery, Mar. 2006, 243(… [cited by applicant]
Mccord, “Oxygen-Derived Free Radicals in Postischemic Tissue Injury,” N Engl J Med. 312(3):159-163 (1985). [cited by applicant]
Mccormack et al., “Use of Severely Steatotic Grafts in Liver Transplantation: A Matched Case-Control Study,” Ann Surg, 246(6):940-948 (2007). [cited by applicant]
Minor et al., “Fibrinolysis in organ procurement for transplantation after cardiocirculatory compromise,” Thromb Haemost, 90(2):361-362 (2003). [cited by applicant]
Mitchell et al., “Energy Metabolism Following Prolonged Hepatic Cold Preservation: Benefits of Interrupted Hypoxia in the Adenine Nucleotide Pool in Rat Liver,” Cryobiology 39:130-137 (1999). [cited by applicant]
Miyagi et al., “The Significance of Preserving the Energy Status and Microcirculation in Liver Grafts from Non-Heart-Beating Donor,” Cell Transplantation 17(1-2):173-178 (2008). [cited by applicant]
Moore et al., “Impact of Donor, Technical, and Recipient Risk Factors on Survival and Quality of Life After Liver Transplantation,” Arch Surg_ 140(3):273-277 (2005). [cited by applicant]
Nelson et al., “An improved ex vivo method of primary porcine hepatocyte isolation for use in bioartificial liver systems,” European Journal of Gastroenterology & Hepatology, 2000, 12 (8):923-930. [cited by applicant]
Okamoto et al., “Successful Sub-Zero Non-freezing Preservation of Rat Lungs at −2C Utilizing a New Supercooling Technology,” Journal of Heart and Lung Transplant 27(10):1150-1157 (2008). [cited by applicant]
PCT International Preliminary Report on Patentability in International Appln. No. PCT/US2010/040663, dated Jan. 4, 2012, 7 pages. [cited by applicant]
PCT International Search Report and Written Opinion in International Appln. No. PCT/US2010/040663, dated Mar. 17, 2011, 11 pages. [cited by applicant]
Peter et al., “Hepatic Control of Perfusate Homeostasis During Normothermic Extrocorporeal Preservation,” Transplantation Proceedings 35(4):1587-1590 (2003). [cited by applicant]
Reddy et al., “Non-Heart-Beating Donor Porcine Livers: the Adverse Effect of Cooling,” Liver Transplantation 111:35-38 (2005). [cited by applicant]
Reddy et al., “Preservation of Porcine Non-Heart-Beating Donor Livers by Sequential Cold Storage and Warm Perfusion,” Transplantation 77(9): 1328-1332 (2004). [cited by applicant]
Rodriguez et al., “Subzero nonfreezing storage of rat hepatocytes using modified University of Wisconsin solution (mUW) and 1, 4-butanediol. I-effects on cellular metabolites during cold storage,” Annals of Hepatology, … [cited by applicant]
Sakaguchi et al., “Preservation of Myocardial Function and Metabolism at Subzero Nonfreezing Temperature Storage of the Heart,” J Heart Lung Transplant 15(11):1101-1107 (1996). [cited by applicant]
Serracino-Inglott et al., “Hepatic ischemia-reperfusion injury,” The American Journal of Surgery 181(12):160-166 (2001). [cited by applicant]
Shah et al., “Adult-to-adult living donor liver transplantation,” Can. J. Gastroenterol., 2006, 20(5):339-343. [cited by applicant]
Soltys et al., “Successful Nonfreezing, Subzero, Preservation of Rat Liver with 2,3-Butanediol and Type I Antifreeze Protein,” Journal of Surgical Research, 96(1):30-34 (2001). [cited by applicant]
ST Peter et al., “Extended preservation of non-heart-beating donor livers with normothermic machine perfusion,” British Journal of Surgery 89:609-616 (2002). [cited by applicant]
Taylor et al., Transplantation Proceedings, 40:480-482 (2008) “Twenty-four hour hypothermic machine perfusion preservation of porcine pancreas facilitates processing for islet isolation.” [cited by applicant]
Terry et al., “Cryopreservation of isolated human hepatocytes for transplantation: State of the art,” Cryobiology, Oct. 2006, 53(2):149-159. [cited by applicant]
Tolbloom et al., “Recovery of warm ischemic rat liver grafts by normothermic extracorporeal perfusion,” Transplantation, Jan. 2009, 87(2):170-77. [cited by applicant]
Tolboom et al., “Sequential Cold Storage and Normothermic Perfusion of the Ischemic Rat Liver,” Transplantation Proceedings 40(5):1306-1309 (2008). [cited by applicant]
Tolboom et al., Tissue Engineering, 13(8):2143-2151 (2007) “A model for normothermic preservation of the rat liver.” [cited by applicant]
Vairetti et al., “Correlation Between the Liver Temperature Employed During Machine Perfusion and Reperfusion Damage: Role of Ca2+,” Liver Transplantation 14:494-503 (2008). [cited by applicant]
Vajdova et al., “ATP-Supplies in the Cold-Preserved Liver: A Long-Neglected Factor of Organ Viability,” Hepatology 36(6):1543-1552 (2002). [cited by applicant]
Vajdova et al., “Cold-Preservation-Induced Sensitivity of Rat Hepatocyte Function to Rewarming Injury and Its Prevention by Short-Term Reperfusion,” Hepatology 32(2):289-296 (2000). [cited by applicant]
Van Der Plaats et al., “The Groningen Hypothermic Liver Perfusion Pump: Functional Evaluation of a New Machine Perfusion System,” Annals of Biomedical Engineering 34(12):1924-1934 (2006). [cited by applicant]
Vollmar et al., “In vivo quantification of ageing changes in the rat liver from early juvenile to senescent life,” Liver, 22(4):330-341 (2002). [cited by applicant]
Zhao et al., “Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury,” The Journal of Biological Chemistry, Aug. 2004, 2… [cited by applicant]
Lim et al., “Effect of immunosuppressive agents on hepatocyte apoptosis post-liver transplantation,” PLOS One, Sep. 2015, 10(9):e0138522, 19 pages (Accepted Manuscript). [cited by applicant]
Wojcicki et al., “Biliary Tract Complications after Liver Transplantation: A Review,” Digestive Surgery, Jul. 2008, 25(4):245-257. [cited by applicant]